Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03810053 · ClinicalTrials.gov registry record · NA
Utilizing Technology to Promote Cancer Prevention
A NA study, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 290
- Enrollment target
NCT03810053: Completed NA study, sponsored by University of Arkansas.
NCT03810053 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 290 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03810053, a NA study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 290 participants
- Enrollment target
Study Summary
The goal of the program is to develop an online module/a health application for cell phones which will share didactic information regarding cancer prevention and early detection measures. These module/application will be developed, and be tested among volunteers for feedback. In the future, these module/application will be disseminated widely to address cancer health disparity particularly in Arkansas.
Primary Outcome
Percentage of participants that indicated they learned something new about cancer prevention measures.
Interventions
- BEHAVIORAL Mobile App/Online Module
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2019-03-01 |
| Est. Completion | 2021-07-14 |
| Phase | NA |
What the finished NCT03810053 record still lists
NCT03810053 is an interventional study that assigns participants to a tested intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which Mobile App/Online Module is the first listed.
NCT03810053 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03810053 about?
NCT03810053 is a clinical study titled "Utilizing Technology to Promote Cancer Prevention". The goal of the program is to develop an online module/a health application for cell phones which will share didactic information regarding cancer prevention and early detection measures. These module/application will be developed, and be tested among volunteers for feedback. In the future, these mo...
What is the current status of trial NCT03810053?
This trial is currently completed. It is a NA study. The enrollment target is 290 participants. The study started on 2019-03-01. Estimated completion is 2021-07-14.
What interventions are being tested in trial NCT03810053?
The interventions under investigation include: Mobile App/Online Module (BEHAVIORAL).
Who is sponsoring clinical trial NCT03810053?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03810053's enrollment target sits among peer trials
290 375th of 2000 higher than 1,625 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI